The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development
Open accessAbstract
BACKGROUND: The complexity and heterogeneity of the human plasma proteome have presented significant challenges in the identification of protein changes associated with tumor development. Refined genetically engineered mouse (GEM) models of human cancer have been shown to faithfully recapitulate the molecular, biological, and clinical features of human disease. Here, we sought to exploit the merits of a well-characterized GEM model of pancreatic cancer to determine whether proteomics technologies allow identification of protein changes associated with tumor development and whether such changes are relevant to human pancreatic cancer. METHODS AND FINDINGS: Plasma was sampled from mice at early and advanced stages of tumor development and from matched controls. Using a proteomic approach based on extensive protein fractionation, we confidently identified 1,442 proteins that were distributed across seven orders of magnitude of abundance in plasma. Analysis of proteins chosen on the basis of increased levels in plasma from tumor-bearing mice and corroborating protein or RNA expression in tissue documented concordance in the blood from 30 newly diagnosed patients with pancreatic cancer relative to 30 control specimens. A panel of five proteins selected on the basis of their increased level at an early stage of tumor development in the mouse was tested in a blinded study in 26 humans from the CARET (Carotene and Retinol Efficacy Trial) cohort. The panel discriminated pancreatic cancer cases from matched controls in blood specimens obtained between 7 and 13 mo prior to the development of symptoms and clinical diagnosis of pancreatic cancer. CONCLUSIONS: Our findings indicate that GEM models of cancer, in combination with in-depth proteomic analysis, provide a useful strategy to identify candidate markers applicable to human cancer with potential utility for early detection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Keller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830
A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Self-citationComparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics
Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G., Mendoza, A., Sevinsky, J. R., Resing, K. A., & Ahn, N. G. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500084-mcp200 · Cited by 1,206
Pancreatic cancer biology and genetics
Bardeesy, N., & DePinho, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc949 · Cited by 1,142
Self-citationIdentification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033 · cited 3×
“Mice harboring Pdx1-Cre Kras Ink4a/Arf lox/lox mutations exhibit stereotypical neoplastic progression from pancreatic cancer precursor lesions (PanINs) present at ;2 wk of age to advanced PDAC by 6 to 10 wk of age [13].”
BackgroundMethodInfluentialSelf-citationMining the plasma proteome for cancer biomarkers
Hanash, S. M., Pitteri, S. J., & Faca, V. M. (2008) · Nature · doi:10.1038/nature06916 · Cited by 891
Self-citationGoonetilleke, K. S., & Siriwardena, A. K. (2007) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2006.10.004 · Cited by 877
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström, I., Raycraft, J., Hayden-Ledbetter, M. S., Ledbetter, J. A., Schummer, M., McIntosh, M. W., Drescher, C. W., Urban, N. D., & Hellström, K. E. (2003) · PubMed · Cited by 711
Self-citationBardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K.-H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 581
Self-citationA Mammalian Organelle Map by Protein Correlation Profiling
Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y., Xie, X., Mootha, V. K., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.022 · Cited by 576
Logsdon, C. D., Simeone, D. M., Binkley, C. E., Arumugam, T., Greenson, J. K., Giordano, T. J., Misek, D. E., Kuick, R. D., & Hanash, S. (2003) · PubMed · Cited by 546
Self-citationKislinger, T., Cox, B., Kannan, A., Chung, C., Hu, P., Ignatchenko, A., Scott, M. S., Gramolini, A. O., Morris, Q., Hallett, M. T., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.044 · Cited by 482
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach
Grønborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500178-mcp200 · Cited by 482
Comprehensive analysis of HE4 expression in normal and malignant human tissues
Galgano, M. T., Hampton, G. M., & Frierson, H. F. (2006) · Modern Pathology · doi:10.1038/modpathol.3800612 · Cited by 437
Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Meyskens, F. L., Omenn, G. S., Valanis, B., & Williams, J. H. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh320 · Cited by 430
Self-citationp16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
Moskaluk, C. A., Hruban, R. H., & Kern, S. E. (1997) · PubMed · Cited by 429
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene
Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon-Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 392
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377
Self-citationGrowth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases
Yuki, K., Hirohashi, S., Sakamoto, M., Kanai, T., & Shimosato, Y. (1990) · Cancer · doi:10.1002/1097-0142(19901115)66:10<2134::aid-cncr2820661016>3.0.co;2-3 · Cited by 329
States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D., Eng, J., Speicher, D. W., & Hanash, S. M. (2006) · Nature Biotechnology · doi:10.1038/nbt1183 · Cited by 325
Self-citationOverexpression of p53 Protein in Adenocarcinoma of the Pancreas
DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van Den Berg, F. M., Allison, D. C., Cameron, J. L., & Johan A. Offerhaus, G. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.6.684 · Cited by 218
Rauch, A., Bellew, M., Eng, J., Fitzgibbon, M., Holzman, T., Hussey, P., Igra, M., Maclean, B., Lin, C. W., Detter, A., et al. (2006) · Journal of Proteome Research · doi:10.1021/pr0503533 · Cited by 215
Self-citationKoopmann, J., Rosenzweig, C. N. W., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M., Yeo, C., Chan, D. W., Breit, S. N., & Goggins, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0564 · Cited by 213
MacLean, B., Eng, J. K., Beavis, R. C., & McIntosh, M. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl379 · Cited by 210
Self-citationQuantitative proteome analysis using isotope-coded affinity tags and mass spectrometry
Shiio, Y., & Aebersold, R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.22 · Cited by 208
Proteins with whey-acidic-protein motifs and cancer
Bouchard, D., Morisset, D., Bourbonnais, Y., & Tremblay, G. M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70579-4 · Cited by 204
Pancreatic Cancer Proteome: The Proteins That Underlie Invasion, Metastasis, and Immunologic Escape
Chen, R., Yi, E. C., Donohoe, S., Pan, S., Eng, J., Cooke, K., Crispin, D. A., Lane, Z., Goodlett, D. R., Bronner, M. P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.001 · Cited by 202
Comprehensive Proteomic Analysis of Human Pancreatic Juice
Grønborg, M., Bunkenborg, J., Kristiansen, T. Z., Jensen, O. N., Yeo, C. J., Hruban, R. H., Maitra, A., Goggins, M. G., & Pandey, A. (2004) · Journal of Proteome Research · doi:10.1021/pr0499085 · Cited by 199
Okamoto, H. (1999) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050115 · Cited by 194
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
McIntosh, M. W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellstrom, K. E., & Hellstrom, I. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.039 · Cited by 193
Self-citationProteomic Analysis of Chronic Pancreatitis and Pancreatic Adenocarcinoma
Crnogorac–Jurcevic, T., Gangeswaran, R., Bhakta, V., Capurso, G., Lattimore, S., Akada, M., Sunamura, M., Prime, W., Campbell, F., Brentnall, T. A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.012 · Cited by 171
Contribution of Protein Fractionation to Depth of Analysis of the Serum and Plasma Proteomes
Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V., Phanstiel, D., Krasnoselsky, A., Zhang, Q., Struthers, J., Wang, H., Eng, J., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070233q · Cited by 164
Self-citationBead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers
Scholler, N., Crawford, M., Sato, A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2007 · Cited by 156
Self-citationChen, R., Brentnall, T. A., Pan, S., Cooke, K., Moyes, K. W., Lane, Z., Crispin, D. A., Goodlett, D. R., Aebersold, R. H., & Bronner, M. P. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700072-mcp200 · Cited by 156
Tenascin C and annexin II expression in the process of pancreatic carcinogenesis
Esposito, I., Penzel, R., Chaib-Harrireche, M., Barcena, U., Bergmann, F., Riedl, S., Kayed, H., Giese, N. A., Kleeff, J. H., Frieß, H., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1935 · Cited by 156
Activated leukocyte cell adhesion molecule: a new paradox in cancer
Ofori-Acquah, S. F., & KING, J. A. C. (2007) · Translational research · doi:10.1016/j.trsl.2007.09.006 · Cited by 132
Wang, H., Clouthier, S. G., Galchev, V., Misek, D. E., Duffner, U. A., Min, C.-K., Zhao, R., Tra, J., Omenn, G. S., Ferrara, J. L. M., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400126-mcp200 · Cited by 132
Self-citationKakisaka, T., Kondo, T., Okano, T., Fujii, K., Honda, K., Endo, M., Tsuchida, A., Aoki, T., Itoi, T., Moriyasu, F., et al. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.01.029 · Cited by 120
Lee, H., Lee, E., Lee, K.-J., Hong, S. W., Yoon, Y., & Kim, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21657 · Cited by 118
Quantitative Analysis of Acrylamide Labeled Serum Proteins by LC−MS/MS
Faça, V. M., Coram, M., Phanstiel, D., Glukhova, V. A., Zhang, Q., Fitzgibbon, M., McIntosh, M. W., & Hanash, S. (2006) · Journal of Proteome Research · doi:10.1021/pr060102+ · Cited by 117
Self-citationChen, R., Pan, S., Cooke, K., Moyes, K. W., Bronner, M. P., Goodlett, D. R., Aebersold, R. H., & Brentnall, T. A. (2006) · Pancreas · doi:10.1097/01.mpa.0000240615.20474.fd · Cited by 105
Bloomston, M., Shafii, A. E., Zervos, E. E., & Rosemurgy, A. S. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2001.6318 · Cited by 96
Biology of insulin-like growth factor binding protein-4 and its role in cancer (review)
Durai, R., Davies, M., Yang, W., Yang, S. Y., Seifalian, A. M., Goldspink, G., & Winslet, M. C. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.6.1317 · Cited by 89
BARBER, M. D., Fearon, K. C. H., & Ross, J. A. (1999) · Clinical Science · doi:10.1042/cs0960083 · Cited by 89
Laurell, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i21.3344 · Cited by 76
Misek, D. E., Kuick, R. D., Wang, H., Galchev, V., Deng, B., Zhao, R., Tra, J., Pisano, M. R., Amunugama, R., Allen, D., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500103 · Cited by 72
Self-citationStandardizing Diagnostic Markers to Evaluate and Compare Their Performance
PEPE, M. S., & Longton, G. (2005) · Epidemiology · doi:10.1097/01.ede.0000173041.03470.8b · Cited by 64
Investigation of the Mouse Serum Proteome
Hood, B. L., Zhou, M., Chan, K. C., Lucas, D. A., Kim, G. J., Issaq, H. J., Veenstra, T. D., & Conrads, T. P. (2005) · Journal of Proteome Research · doi:10.1021/pr050107r · Cited by 54
Comparative proteomic analysis of human pancreatic juice: Methodological study
Zhou, L., Lu, Z., Yang, A., Deng, R.-X., Mai, C., Sang, X., Faber, K. N., & Lu, X. (2007) · PROTEOMICS · doi:10.1002/pmic.200600086 · Cited by 51
Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer
Shu-qing, S. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i19.3119 · Cited by 31
Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer
Wang, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i43.5692 · Cited by 26
Cited by
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Day, C.-P., Merlino, G., & Van Dyke, T. (2015) · Cell · doi:10.1016/j.cell.2015.08.068 · Cited by 676
Wang, J., Chen, J., Chang, P., LeBlanc, A., Li, D., Abbruzzesse, J. L., Frazier, M. L., Killary, A. M., & Sen, S. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0094 · Cited by 559
Genetics and biology of pancreatic ductal adenocarcinoma
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development · doi:10.1101/gad.275776.115 · Cited by 527
Metadata
- Authors
- Faca, V. M., Song, K. S., Wang, H., Zhang, Q., Krasnoselsky, A. L., Newcomb, L. F., Plentz, R. R., Gurumurthy, S., Redston, M. S., Pitteri, S. J., Pereira-Faca, S. R., Ireton, R. C., Katayama, H., Glukhova, V., Phanstiel, D., Brenner, D. E., Anderson, M. A., Misek, D., Scholler, N., Urban, N. D., Barnett, M. J., Edelstein, C., Goodman, G. E., Thornquist, M. D., McIntosh, M. W., DePinho, R. A., Bardeesy, N., & Hanash, S. M.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-06-10
- Volume
- 5
- Issue
- 6
- Pages
- e123
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2156250197
- Cited by
- 257
- References
- 58
- FWCI
- 16.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.